NEUROBO PHARMACEUTICALS NRBO 深 沪
已收盘 11-27 16:00:00 美东时间
2.36
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.36
- 总市值 2033.38万
- 52周最高 6.7499
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.08
- 委 比 0.00%
- 总股本 861.60万
- 历史最高 138900.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.08
- 每 手 1
- 风险率 0.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update
Top-Line Data From MAD Part 2 of the Phase 1 Trial of DA-1726 Expected in April of 2025 Announced Positive Top-Line 16-Week Results from the Phase 2a Trial of DA-1241 for the Treatment of MA...
03-20 19:31
NeuroBo Pharmaceuticals Reveals Promising Therapeutic Developments
An announcement from NeuroBo Pharmaceuticals ( ($NRBO) ) is now available. Meta...
2024-11-29 22:28
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
NeuroBo Pharmaceuticals ( ($NRBO) ) just unveiled an update. NeuroBo Pharmaceut...
2024-11-18 21:59
Watching NeuroBo Pharmaceuticals; Zacks Small-Cap Research Gives Stock $22 Price Valuation
https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_11132024_NRBO_Bautz.pdf
2024-11-14 01:58
NeuroBo Pharmaceuticals Completes Phase 2a Trial for MASH Drug
NeuroBo Pharmaceuticals ( ($NRBO) ) has issued an announcement. NeuroBo Pharmac...
2024-11-04 21:58
Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Seeking Alpha's earnings calendar for a full list of companies due to report....
2024-10-12 03:00
NeuroBo Pharmaceuticals Unveils Updated Corporate Presentation
An announcement from NeuroBo Pharmaceuticals ( ($NRBO) ) is now available. Neur...
2024-10-07 19:29
NeuroBo Pharmaceuticals GAAP EPS of -$1.85
NeuroBo Pharmaceuticals press release (NASDAQ:NRBO): Q2 GAAP EPS of -$1.85. Cash was approximately $27.9 million as of June 30, 2024, compared to approximately $22.4 million as of December 31, 2023. M...
2024-08-15 23:57
NeuroBo Pharmaceuticals Q2 EPS $(1.85) Misses $(1.12) Estimate
NeuroBo Pharmaceuticals (NASDAQ:NRBO) reported quarterly losses of $(1.85) per share which missed the analyst consensus estimate of $(1.12) by 65.18 percent. This is a 12233.33 percent decrease over losses of $(0.01) per
2024-08-14 20:15
快讯 | neurobo pharmaceuticals: Da-1241治疗骨折瘀血的二期a试验第2部分正在进行中，预计在2024年第4季度公布头条数据。
NeuroBo Pharmaceuticals: Part 2 of Phase 2a Trial of Da-1241 for Treatment of M...
2024-08-14 20:03
